Back to trial details

Intake questionnaire

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Applying to Rush University Medical Center · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you between 18 and 70 years old?
2. Have you been diagnosed with Crohn's Disease?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Chicago for study visits?